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Abstract 
This  thesis  deals  with  the  molecular  characterization  and  detection  of  infectious 
bronchitis virus (IBV), an important pathogen that causes heavy losses in the poultry 
populations worldwide. The aim of the research was to better understand the molecular 
characteristics  of  the  virus  and  to  investigate  the  factors  behind  the  continuous 
emergence  of  new  genetic  variants  and  the  occurrence  of  outbreaks.  The  studies 
showed that the viral genome is under a continuous evolution, due to mutations, strong 
selective  pressure  and  recombination  events.  These  forces  lead  to  a  wide  genetic 
diversity and the generation of new variants of this virus. The viral genes encoding the 
spike, replicase and nucleocapsid proteins can be considered the main genomic regions, 
which  are  indicating  the  evolution  processes  of  IBV.  The  various  strains  contain 
specific  structural  and  functional  motifs  in  their  genes  and  the  alterations  in  these 
motifs may affect the infection biology of the virus. The constant emergence of new 
variants in Sweden is likely due to the introduction of novel IBV strains from other 
European  countries  through  the  import  of  poultry  products,  or  by  the  continuous 
migration of wild birds.  
The  in  silico  investigations  of  the  spike  glycoprotein  coding  regions  of  the 
Massachusetts  and  QX-like  genotypes  demonstrated  molecular  differences  between 
these genotypic variants. It is hypothesized that the genetic diversity in the spike gene 
of IBV and of other avian coronaviruses, as well as of human, bat, and other animal 
coronaviruses  could  be  associated  with  the  adaptation  and  host  specificity  of  these 
infectious agents.   
The data obtained by molecular characterization approach was also used for the 
development of a new molecular method for the improved detection and genotyping of 
this virus. A microarray platform was developed for the simultaneous detection and 
rapid typing of IBV variants. This assay provides a practical tool for better diagnosis, 
for  studying  the  effectiveness  of  vaccination  and  for  performing  large-scale 
epidemiological studies.     
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1  Introduction 
1.1  History of infectious bronchitis   
Infectious bronchitis (IB) is a highly contagious disease of serious economic 
importance in the poultry industry worldwide. The first report of IB by Schalk 
and  Hawn  referred  to  a  highly  contagious  disease  in  young  chicks  with 
respiratory symptoms in North Dakota, USA in 1931 (Schalk & Hawn, 1931). 
Pathogenic  alterations  in  the  upper  respiratory  tract  of  the  birds  were 
prominent;  hence  the  disease  was  named  “infectious  bronchitis  of  young 
chicks”. Five years later, it was demonstrated that the causative agent of this 
disease is a virus, which was named Infectious Bronchitis Virus (IBV) (Beach 
& Schalm, 1936). After the initial description of infectious bronchitis, many 
cases of the disease were reported in the United States (Jungherr et al., 1956; 
Hitchner  et  al.,  1966;  Johanson  et  al.,  1973;  Snyder  &  Marquardt,  1984; 
Fabricant,  1998;  Hitchner,  2004).  Thereafter  and  to  date,  a  wide  range  of 
different IBV serotypes and genotypes have been detected around the world 
(Jackwood et al., 1997; de Wit et al., 2011). 
1.2  Clinical features of infectious bronchitis  
Clinical cases of IB are associated with respiratory, reproductive, digestive and 
renal  infections  in  domestic  poultry  and  in  various  other  avian  species 
(Cavanagh, 2005). The disease is clinically manifested by coughing, sneezing, 
tracheal  coarse  crackles,  nasal  discharge,  decrease  of  feed  intake  and 
conversion, loss of body weight, swollen sinuses, increased water intake, wet 
droppings,  depression,  lethargy  and  poor  growth  in  broilers.  In  layers  the 
disease,  “false  layer  syndrome”,  affects  egg  quality  (thin,  rough,  fragile, 
misshapen  egg  shells  and  thin  watery  egg)  and  causes  decrease  in  egg 
production. In some cases, the virus infection may cause severe damage to the 12 
oviduct and result in decreased or permanent loss of egg production (Otsuki et 
al.,  1990;  Fabricant,  1998;  Cavanagh,  2003;  Cavanagh  &  Naqi,  2003; 
Cavanagh & Gelb, 2008; Worthington et al., 2008). IB infections may lead to 
mortality up to 20-30% or higher at five to six weeks of age in chicken flocks 
(Ignjatovic et al., 2002; Seifi et al., 2010). The mortality can increase due to 
immunosuppression,  mycoplasma  and  other  secondary  bacterial  infections 
caused  by  various  accompanying  infectious  agents,  e.g.  Escherichia  coli, 
Ornithobacterium  rhinotracheale  and  Bordetella  avium  (Hopkins  &  Yoder, 
1984; Matthijs et al., 2003; Cavanagh & Gelb, 2008). The mortality rate can be 
as low as 1% and chickens may recover rapidly, if the infections are produced 
by  mildly  virulent  strains  and  are  not  associated  with  secondary  bacterial 
infections (Cavanagh & Gelb, 2008).    
1.3  Host specificity 
IBV infects a wide range of avian species, especially those reared close to 
domesticated  poultry,  for  example  domestic  fowl,  partridge,  geese,  pigeon, 
guinea fowl, teal, duck and peafowl (Cavanagh, 2005; Cavanagh, 2007). In 
different hosts, the virus exhibits considerable similarities in its genome. For 
example,  a  virus  that  was  isolated  from  teal  and  peafowl  shared  90-99% 
sequence related to IBV (Liu et al., 2005). Evidence based on the nucleotide 
sequences of viruses isolated from samples of ducks, whooper swans, turkeys 
and pheasants have also shown high similarity to IBV (Breslin et al., 1999; 
Guy, 2000; Cavanagh et al., 2001; Jonassen et al., 2005; Hughes et al., 2009).  
1.4  Mode of transmission  
IBV is a highly infectious pathogen, and the infected birds usually develop 
clinical signs very rapidly, within 36-48 hours. The virus replicates primarily in 
the  upper  respiratory  tract,  leading  to  viraemia,  and  then  spreads  to  other 
organs (Raj & Jones, 1997). Usually, the virus is present in high concentrations 
in the upper respiratory tract during the first 3-5 days post infection (Cook, 
1968; El-Houadfi et al., 1986). In general, a large amount of virus is detected 
in  tracheal  mucus  and  faeces  during  the  acute  and  recovery  phases  of  the 
disease. In some cases IBV persists as a latent infection, and the carrier birds 
continue to shed virus particles via faeces. The virus is transmitted horizontally 
by  the  contaminated  feed,  water  or  faeces.  Infected  birds  shed  the  virus 
continuously in the environment and contaminate their surroundings, such as 
equipment, eggs, also working personnel and trucks, among others, which are 
the major sources of indirect transmission to different regions (Ignjatović & 13 
Sapats,  2000).  Wild  birds  may  play  a  crucial  role  as  reservoirs  and  long-
distance carriers of IBV (Chen et al., 2009; Hughes et al., 2009).  
1.5  Infectious Bronchitis Virus 
1.5.1 Morphology and genome organization 
IBV  belongs  to  the  order  Nidovirales,  family  Coronaviridae,  genus 
Gammacoronavirus (Gonzalez et al., 2003). The enveloped viral particles are 
round and pleomorphic in shape. The virions are approximately 120 nm in 
diameter and contain club-shaped surface projection called spikes, which are 
20 nm in size (Cavanagh & Gelb, 2008). The positive sense RNA genome is 
approximately  27.6  kb  in  size  and  is  encompassing  5′  and  3′  untranslated 
regions (UTRs) with a poly(A) tail (Figure 1) (Boursnell et al., 1987; Ziebuhr 
et al., 2000; Mo et al., 2012). A major part of the genome is organized as two 
overlapping open reading frames (ORFs), 1a and 1b, which are translated into 
large polyproteins 1a and 1ab through a ribosomal frame shift mechanism. The 
remaining part of the genome consists of regions coding for the main structural 
proteins spike (S), envelope (E), membrane (M) and nucleocapsid (N). Two 
accessory genes have been described, ORF3 and ORF5, that express accessory 
proteins 3a & 3b and 5a & 5b, respectively (Lai & Cavanagh, 1997; Pasternak 
et al., 2006). 
 
Figure 1. A schematic genome organization of the infectious bronchitis virus 
1.5.2 Untranslated regions 
The small structural motifs of the IBV genome comprise 5  and 3  untranslated 
regions  (UTRs),  which  mediate  physical  interactions  between  UTRs,  viral 
encoded replicase proteins and host cellular proteins (Li et al., 2008).  14 
1.5.3 Replicase proteins  
Two-thirds  of  the  genome  consists  of  ORF1a  and  ORF1b  that  encode 
polyproteins  1a  and  1ab,  respectively,  and  contribute  to  formation  of  the 
replication and transcription complex (Imbert et al., 2008). These polyproteins 
are post-transitionally cleaved to generate 15 non-structural proteins (Nsp2-
16), comprising a main protease called 3C-like protease, a papain-like protease 
(PL
pro), an RNA-dependent RNA-polymerase (RdRp) and other non-structural 
proteins (van Hemert et al., 2008). 
1.5.4 Spike glycoprotein  
The  spike  glycoprotein  of  all  coronaviruses  contains  four  domains  that  are 
involved in anchoring of the S protein into the lipid bilayer of the virion. The 
IBV S gene consists of 1162 amino acids, and is cleaved into two sub-units, the 
N-terminal S1 subunit (535 amino acids) and the C-terminal S2 subunit (627 
amino  acids).  The  S1  subunit  contains  virus  neutralization  and  serotype-
specific antigenic determinants that are responsible for binding to the host cell, 
neutralization and immune response (Koch et al., 1990; Schultze et al., 1992; 
Ignjatovic  &  Galli,  1994;  Johnson  et  al.,  2003).  The  nucleotide  sequence 
variation  in  the  spike  gene  may  result  in  a  lower  cross  protection  between 
serotypes. The high variation in the nucleotide sequences of spike gene can 
change  the  protection  ability  of  a  vaccine  or  immunity  (Cavanagh,  2003; 
Cavanagh & Gelb, 2008). The S2 sub-unit contains a fusion peptide-like region 
and two heptade regions approximately 100 to 130 Å in length (771-879 amino 
acid in IBV) that are involved in oligomerisation of the protein and entry into 
susceptible host cells (Tripet et al., 2004; Guo et al., 2009; Shulla & Gallagher, 
2009). 
1.5.5 The 3a and 3b proteins 
Gene  3  contains  two  ORFs  (ORF3a  and  ORF3b)  that  are  functionally 
tricistronic  in  nature  (Liu  et  al.,  1991).  ORF3a  and  ORF3b  contain  highly 
conserved nucleotide sequence regions (Mo et al., 2012), not only in IBV but 
also in other gammacoronaviruses (Cavanagh et al., 2001; Cavanagh et al., 
2002).   
1.5.6 Envelope protein  
The envelope protein is a small integral membrane protein associated with the 
envelope of the virions (Smith et al., 1990; Liu & Inglis, 1991). It has been 
demonstrated that the E protein is essential for virus assembly (Maeda et al., 
1999). Mutations in the amino acid sequence of the E protein in coronaviruses 15 
may considerably affect the assembling of the virus in cells (Fischer et al., 
1998). 
1.5.7 Membrane protein 
The largest portion of the integral membrane protein is embedded within the 
lipid bilayer, which maintains the structural integrity (Godet et al., 1992). The 
M  protein  is  responsible  for  the  organization  and  assembling  of  the  virus 
particle by interactions with other structural proteins (Vennema et al., 1996; 
Hogue & Machamer, 2008). 
1.5.8 The 5a and 5b proteins 
Gene 5 is encompassing two ORFs (ORF5a and ORF5b) that encode the 5a 
and 5b proteins, respectively (de Vries et al., 1997). It has been demonstrated 
that these proteins are functionally bicistronic (Pendleton & Machamer, 2005).  
1.5.9 Nucleocapsid protein 
The N protein consists of 409 amino acids. This protein is involved in a variety 
of  functions  such  as  viral  packing,  assembly,  viral  core  formation,  signal 
transduction and modulating host cell processes (Drees et al., 2001; He et al., 
2004; You et al., 2007). 
1.6  Post-transcriptional and post-translational modifications and 
structural motifs 
The post-transcriptional and post-translational modifications such as cleavage, 
palmitoylation,  N-glycosylation,  phosphorylation  and  structural  motifs 
Leucine-rich repeat have important role in virus biology. Therefore, there is 
need  to  explore  these  modifications  and  structural  motifs  especially  by 
application bioinformatics, to identify the differences in the spike glycoprotein 
of the virus variants, in order to bridge a platform for the in-vivo and in-vitro 
studies, which is part of scope of the present thesis.     
1.6.1 Cleavage site motif  
The spike glycoprotein contains a protease cleavage site motif that is involved 
in cleavage of the S1 and S2 sub-units during viral maturation (Cavanagh et al., 
1986). The cleavage site motif of IBV comprises one or two pairs of basic 
amino  acids  that  is  cleaved  by  host  cell  serine  proteases  (Cavanagh  et  al., 
1992).  The  serine  proteases  of  host  cell  catalyze  hydrolyses  reactions  that 
cause cleavage of peptide bonds (Voet & Voet, 1990).  16 
1.6.2 Palmitoylation  
Palmitoylation is the binding of organic molecules, e.g., palmitic acid, to the 
cysteine residues of membrane proteins (Linder, 2000). Palmitoylation plays an 
important role in localization and transport at the sub-cellular level, in protein-
protein interactions, and in various physiological characteristics of proteins in 
the  virus  (Dunphy  &  Linder,  1998;  Dietrich  &  Ungermann,  2004).  The 
carboxyl- terminal cysteine peptides of viral membrane glycoproteins act as 
crucial palmitoylation sites (Ponimaskin & Schmidt, 1995; Petit et al., 2007). 
In  coronaviruses,  palmitoylation  of  viral  glycoproteins  affects  the  fusion  to 
cellular membranes, viral assembly and infection of cells (Bos et al., 1995; 
Petit et al., 2007). 
1.6.3 N-glycosylation  
The N-glycosylation characteristics of viral glycoprotein are associated with 
changes of virulence and cellular tropism (Li et al., 2000). Glycosylation in the 
spike  and  membrane  glycoproteins  of  coronaviruses  is  involved  in  fusion, 
receptor  binding  and  antigenic  characteristics  (Alexander  &  Elder,  1984; 
Braakman & van Anken, 2000; de Haan et al., 2003; Wissink et al., 2004). 
Variation in N-glycosylation sites can affect the interaction with receptors, and 
thus  render  a  virus  more  susceptible  to  host  innate  immune  responses  and 
lower  recognition  by  antibodies,  affecting  virus  replication  and  infectivity 
(Meunier et al., 1999; Land & Braakman, 2001; Slater-Handshy et al., 2004; 
Vigerust & Shepherd, 2007). 
1.6.4 Phosphorylation 
Protein  phosphorylation  plays  a  crucial  role  in  the  regulation  of  functional 
activities  in  microorganisms  (Ingrell  et  al.,  2007).  For  IBV,  two 
phosphorylated  clusters  (Ser190  &  Ser192 and Thr378  &Ser379)  that  were 
identified by a mass spectroscopic method, are located in the middle and C-
terminal  regions  of  the  N  protein  (Chen  et  al.,  2005).  The  C-terminal 
phosphorylation clusters are associated with the differentiation of viral RNA 
from non-viral RNA (Spencer et al., 2008).  
1.6.5 Leucine-rich repeat  
The leucine-rich repeat (LRR) domain is contained in microbial proteins and is 
associated  with  innate  immunity  (Huang  et  al.,  2008).  Beyond  innate 
immunity,  LRR-containing  proteins  are  associated  with  various  cellular 
processes including apoptosis, ubiquitin-related processes and nuclear mRNA 
transport (Kobe & Kajava, 2001; Wei et al., 2008). 
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1.7  Genetic forces 
The genetic forces such as  mutations, recombination  and selective pressure 
play significance role in the viral genome evolution (Zhang et al., 2006; Liu et 
al.,  2007).  In  order  to  better  understand  the  contribution  of  these  forces  in 
genetic diversity of IBV, these were outlined as subjects of thesis.  
Recombination commonly occurs between two or more viruses infecting 
the same cell. It is believed that a high rate of recombination events occurs in 
the genomes of non-segmented RNA viruses (Makino et al., 1986), such as in 
IBV and in other coronaviruses (Lim et al., 2011; Thor et al., 2011; Jackwood 
et  al.,  2012).  In  RNA  viruses,  a  unique  copy  choice  mechanism  during 
polymerase activity allows a high efficiency of RNA recombination (Liao & 
Lai, 1992). Moreover, recombination, along with the polymerase error rate, is 
involved  in  molecular  mechanisms  that  are  likely  to  be  responsible  for 
changing tissue and host species tropism of the virus (Graham & Baric, 2010). 
In the case of coronaviruses, mutations and selective pressure in genes, 
especially in hypervariable regions, enable the virus to cross the species barrier 
and adapt to new host species, hence contributing to viral evolution (Zhang et 
al., 2006; Liu et al., 2007). It has been demonstrated that during the multiple 
passages of IBVs in embryonated eggs, mutations and recombination result in 
strong selective pressure in the S1 gene, leading to the generation of attenuated 
viruses (Liu et al., 2007). 
1.8  Serotypes and genotypes of Infectious Bronchitis Virus 
A number of IBV serotypes, e.g. Arkansas, Connecticut (Conn), Massachusetts 
(Mass), 4/91 or 793B, D274, H120, Italy-02, Baudette, California, Georgia 98 
and QX have been identified and reported around the globe (Lee & Jackwood, 
2001; Jackwood et al., 2003; Sjaak de Wit et al., 2011). Serotyping of IBV 
strains is usually carried out by test systems based on chicken-induced IBV 
serotype-specific  epitope(s)  (Koch  et  al.,  1990;  Keeler  et  al.,  1998).  The 
appearance of a large number of IBV variants in different regions is a major 
constraint for the practical application of serotyping (Sjaak de Wit et al., 2011). 
It  is  important  to  note  that  serotyping  of  IBV  is  becoming  less  and  less 
common today, since the serological tests require a panel of serotype specific 
antibodies, which is not easy to obtain. Thus, recently the typing of the virus is 
mostly performed by various molecular methods as many types of the virus are 
diagnosed by molecular methods.  
Genotyping of IBV is based on the amplification of the highly variable 
sequence  region  of  the  S1  gene  by  reverse  transcriptase  polymerase  chain 
reaction (RT-PCR), followed by sequencing (Jackwood et al., 1992; de Wit, 18 
2000).  The molecular diagnostic assays revealed that different genotypes, such 
as Massachusetts, 4/91, D274, Italy-02 and European QX-like, are circulating 
in European countries (Figure 2) such as Belgium, Denmark, France, Hungary, 
Italy, Germany, The Netherlands, Poland, Russia, Slovenia, Spain, Sweden and 
UK (Davelaar et al., 1984; Parsons et al., 1992; Farsang et al., 2002; Jones et 
al., 2005; Bochkov et al., 2006; Domanska-Blicharz et al., 2006; Worthington 
& Jones, 2006; Dolz et al., 2008; Worthington et al., 2008; Benyeda et al., 
2009; Handberg et al., 2009; Valastro et al., 2010; Krapez et al., 2011; Abro et 
al., 2012a; Abro et al., 2012b). 
 
Figure 2. A phylogenetic tree, based on the comparative analysis of S1 gene 
sequences of different strains obtained from various countries, is showing the 
occurrence of different genotypes of IBV in Europe. 19 
1.9  Detection of Infectious Bronchitis Virus  
Due to constant evolution, there is continuous emergence of new IBV variants 
all over the world. For example, different genotypes such as Massachusetts, 
4/91, D274, Italy-02 and European QX-like are currently circulating in Europe. 
Various methods are used for the detection and identification of IBV. The most 
common  assays  for  routine  diagnosis  are  virus  isolation,  haemagglutination 
inhibition  (HI),  enzyme-linked  immunosorbent  assay  (ELISA), 
immunoperoxidase  assay  (IPA),  virus  neutralization  test  (VNT), 
immunofluorescence assay (IFA), agar gel precipitation test (AGPT), RT-PCR 
and  real-time  RT-PCR  (de  Wit,  2000).  The  majority  of  the  conventional 
diagnostic assays in fact are time- and material-consuming, laborious, costly 
and provide relatively low specificity and sensitivity (King & Hopkins, 1983; 
Mockett & Cook, 1986; Karaca & Naqi, 1993; Naqi et al., 1993; De Wit et al., 
1995; de Wit et al., 1997; de Wit, 2000). Various real-time RT-PCR assays 
have been recently elaborated in veterinary medicine for the diagnosis of a 
variety of infectious pathogens (Belák, 2007). Accordingly, a range of real-
time  RT-PCR  assays  has  been  developed  for  the  specific  detection  of  IBV 
using various approaches, such as the TaqMan technology. In the general real-
time RT-PCR technique is highly sensitive and it can be applied not only for 
the rapid detection and identification of IBV, and even to quantify genomic 
RNA in clinical samples (Callison et al., 2006). On the other hand, sometimes 
even the real-time RT-PCR assay may lead to poor results due to limitations in 
detecting the divergent or the new virus variants. In addition, being based on 
the conserved 5’ UTR or the nucleocapsid genes, the amplicons obtained by 
diagnostic PCR assays are not suitable for determining the types of the viruses. 
The virus typing, in majority of the cases is based on the comparative analysis 
of nucleotide sequences of the variable S gene.  
Considering  that  there  are  no  reliable  and  practical  assays  available 
today, that can simultaneously detect and type IBV variants; the development 
of such an assay was contemplated in the present work. By applying variation-
tolerant detection chemistry and the Luminex technology, we have developed a 
new  tool  for  the  rapid  detection  and  accurate  identification  of  various 







2  Aims of the studies 
The  overall  objectives  of  the  present  studies  were  to  characterize  various 
strains of IBV, to determine genetic diversity and to investigate the factors 
driving the evolution of this virus. A further task was, to develop a molecular 
diagnostic assay, in order to improve the detection and typing of IBV variants 
causing disease outbreaks in Sweden and in other European countries.  
 
The specific aims were: 
 
  To perform molecular characterization of IBV isolates from Sweden 
based  on  the  comparative  sequence  analysis  of  the  complete  spike 
gene, in order to better understand the epidemiology and the factors 
behind the occurrence of new outbreaks (Paper I). 
  To study the full-length genome of the European QX-like isolate of 
IBV, detected in Sweden, by sequencing and phylogenetic analysis 
(Paper II). 
  To compare the molecular characteristics of isolates belonging to the 
classical Massachusetts and emerging QX-like genotypes of IBV in 
order to determine differences in potential functional and structural 
motifs of the spike gene that may relate to the biological properties of 
the virus. In addition, a comparative analysis of the complete spike 
gene  was  performed  based  on  sequences  of  avian  and  mammalian 
coronaviruses (Paper III). 
  To develop a specific assay for the simultaneous detection and typing 
of  the  QX-like,  Italy-02,  M41,  4/91  and  D274  genotypes  of  IBV, 
which are currently circulating in Europe (Paper IV). 
 





3  Materials and methods 
3.1  Samples and screening for Infectious Bronchitis Viruses 
Clinical  samples  (trachea,  bronchi,  ceaca)  were  obtained  from  different 
outbreaks in Sweden (Papers I, II, III and IV). The D274, Italy-02 and 4/91 
isolates kindly provided from the Netherlands, Slovenia and France (Merial) 
were used in the study (Paper IV). The samples were screened by real-time 
RT-PCR assay as described by Callison et al. (2006) for the presence of IBVs 
(Papers I and IV).  
3.2  Isolation of Infectious Bronchitis Viruses 
The  real-time  RT-PCR  positive  IBV  samples  were  propagated  in  specific 
pathogen-free (SPF) embryonated hen’s eggs. Virus isolation was performed 
by inoculation of 9–11 day old eggs with 200 µl of 10% tissue homogenates 
and incubation at 37 
oC for 72 hours. The allantoic fluid was harvested, and 
isolates were stored at -20 
oC for the further use.  
3.3  RNA extraction, synthesis of cDNA, PCR amplification and 
sequencing 
The  viral  RNA  was  extracted  using  the  TRIzol  reagent  according  to  the 
manufacturer’s instructions (Invitrogen, Carlsbad, USA) (Papers I, II, and IV). 
Synthesis  of  cDNA  was  performed  with  gene  specific  primers  using 
SuperScript II reverse transcriptase (Invitrogen
TM Life technologies, Carlsbad, 
USA)  as  recommended  by  the  manufacturer  (Papers  I  and  II).  PCR 
amplification  and  sequencing  were  performed  for  the  S  gene  and  also  for 
fragments covering the whole genome (Papers I, II and IV). Different pairs of 
primers were used for amplification and sequencing of the full-length genome 24 
as  reported  by  Liu  et  al.  (2009)  (Paper  II).  The  sequencing  reactions  were 
performed by using Big Dye terminator sequencing kit (Applied Biosystems, 
Foster City, CA), as recommended by the manufacturer (Papers I, II, and IV). 
For sequence analysis, the sequence data set was pair wise edited and aligned 
with the software Lasergene DNASTAR (Madison, USA) (Papers I, II and IV). 
3.4  Recombination analysis  
The recombination analyses were performed on the complete gene sequences 
using the Recombination Detection Program (RDP v3.44) (Martin et al., 2010). 
Different methods available in the program were applied in order to compare 
and accurately determine the positions of the recombination hot spots and to 
differentiate closest fragment of non-recombinant sequences (Ohshima et al., 
2007).  The  marker  positions  were  indexed  for  the  determination  of 
recombinant clusters (Papers I and II).  
3.5  Selection pressure 
Evidence of selective pressure in individual genes was examined by using the 
SNAP  (Korber  et  al.,  2000)  services  available  at  web  server 
http://hcv.lanl.gov/content/sequence/SNAP/SNAP.html (Papers I and II). The 
differences between synonymous (dS) and non-synonymous (dNS) amino acid 
substitutions were calculated in order to determine the substitution rate in the 
analyzed gene(s) individually (Papers I and II).  
3.6  Analysis of functional and structural motifs 
As reported in Paper III, N-glycosylation sites were predicted using services 
available  at  web  server  http://www.cbs.dtu.dk/services/NetNGlyc.  The 
potential  phosphorylation  sites  were  determined  by  using  the  website 
http://www.cbs.dtu.dk/services/NetPhos. The cleavage site motif analysis was 
performed by  the traditional approach using the amino acid position in the 
sequence  of  the  spike  glycoprotein,  as  previously  described  by  (Parker  & 
Masters, 1990; Jackwood et al., 2001). LRR regions were identified by LRR 
finder, available at http://www.lrrfinder.com/result.php. The primary structures 
of  the  spike  glycoprotein  were  predicted  by  http://expasy.org/tools.  The 
secondary structures were predicted by the GOR4 method using services at 
http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_gor4.html.  The 
palmitoylation  sites  were  determined  with  the  medium  threshold  frequency 
using web domain http://csspalm.biocuckoo.org/prediction.php.  25 
3.7  Phylogenetic analysis 
As described in Papers I, II and III, phylogenetic analysis was performed using 
sequences generated in these studies, as well as sequence data downloaded 
from the GenBank database. Phylogenetic relationship was determined using 
both  parsimony  and  nucleotide  distance  methods.  The  nucleotide  distance 
matrix between sequences was used to construct a phylogeny by Neighbor-
Joining (NJ) using MEGA 4 (Tamura et al., 2007). The NJ method was applied 
because it is relatively fast and can be suitable for large data sets (Tamura et 
al., 2004). The sequences were compared by using the gamma Tamura–Nei 
model  (Tamura  &  Nei,  1993).  Bayesian  analyses  were  performed  by  using 
MrBayes 3.1 software (Ronquist & Huelsenbeck, 2003).    
3.8  Variation-tolerant capture multiplex assay (VOCMA) 
As  reported  in  Paper  IV,  synthetic  targets  were  designed  as  an  alternative 
positive  control  for  each  genotype:  M41,  D274,  4/91,  Italy-02,  QX-like, 
IBV_Capsid (consensus). The hybridization events of variation tolerant (VT) 
were designed using the NucZip algorithm (Öhrmalm et al., 2010; Öhrmalm et 
al., 2012).  
The amplification of target nucleic acid by VOCMA, executed as single-
tube one-step multiplex amplification, was performed using long specific VT 
primer-probes and short generic primers, with the biotinylated generic second 
primer.  The  extracted  nucleic  acid  or  synthetic  ssDNA  target  was  added 
directly to a mastermix one-step RT-PCR mixture. Specific synthetic 5  amino-
C12 modified detection probes for the different IBV genotypes were designed 
and  coupled  to  xMAP  carboxylated  colour-coded  microspheres  (Luminex 
Corp.,  Austin  TX,  USA)  according  to  the  manufacturer’s  instructions 
(Luminex  Corporation,  Austin  TX,  USA).  The  biotin-labeled  amplified 
template was mixed with hybridization buffer of each probe-coupled xMAP 
bead. The IBV VOCMA has six unique beads, each coupled with either six 
specific VT detection probes of 48-62 nt (long probes) or of 33-36 nt (short 
probes). The mixture was treated at 95 ºC for 2 min, followed by hybridization 
at 50 ºC for 30 min with shaking at 600 rpm on a Thermostar (BMG LabTech; 
Offenburg, Germany) microplate incubator. After a short centrifugation, 40 µL 
of  supernatant  was  discarded  and  a  mixture  of  38µL  3M  TMAC-TE 
hybridization  buffers  +  2  µL  of  Streptavidin-R-phycoerythrin  (QIAGEN, 
Hilden, Germany) was added. The tubes were further incubated at 50 ºC for 15 
min,  before  analysis  for  internal  bead  and  R-phycoerythrin  reporter 
fluorescence on the Luminex®200™ flow meter (Luminex corporation, Austin 26 
Tx).  The  quantity  of  biotinylated  target  that  hybridized  to  the  probe-linked 
beads was measured as Median Fluorescence Intensity (MFI).  
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4  Results and discussion 
4.1  Characterization and genetic diversity of the S gene of IBV 
(Papers I and III) 
Outbreaks of infectious bronchitis have been detected in Sweden between 1995 
and 2010. Twenty samples originating from these outbreaks were selected for 
molecular characterization based on analysis of sequences of the complete S 
gene  (Paper  I).  The  viruses  collected  in  1995-1999  showed  nucleotide 
sequence difference of varying degree 18.7-21% in comparison to the isolates 
from 2009-2010. The isolates from the 1990s shared lower identities to the 
viruses collected in the 2000s, reflecting the genetic signature of new variants. 
Considerable sequence variation was found in the region encompassing the S1 
part of the S gene. In the S2 subunit, regions of sequence variation were found 
interspaced  with  regions  of  high  conservation,  also  contributing  to  overall 
diversity of the S gene. The variation in nucleotide sequences of the S1 region 
may lead to alter the virus characteristics such as epitopes and receptor binding 
abilities. It has been reported that comparative analysis of the hypervariable 
region of the S1 nucleotide sequences is a suitable tool for the discrimination 
of various IBV field variants (Kusters et al., 1987; Kwon et al., 1993; Wang & 
Huang,  2000).  There  were  nucleotide  insertions  and  deletions  at  different 
locations in the spike gene of isolates from the 2000s in comparison to isolates 
from the 1990s. The nucleotide insertions, deletions and point mutations in the 
S gene contribute to evolution of IBV (Kusters et al., 1990; Lai, 1992; Kottier 
et  al.,  1995).  The  significant  substitutions  in  the  S1  region  warrant  further 
investigation to ascertain their relevance, if any, in the virus biology. 
Substitutions in the coding sequences are likely attributable to strong 
positive  selection  pressures  in  the  spike  gene.  Strong  selective  constraints 
could affect the primary and secondary structures of the gene, which may lead 
to alteration of genetic and molecular features of the virus. It has been reported 28 
that positive selection in IBV can lead to emergence of new strains that are 
capable of escaping the immune system (Dolz et al., 2008).  
Recombination  events  were  detected  in  the  spike  gene  sequences  of 
isolates  from  2009-2010  (Paper  I).  This  is  an  important  information, 
considering  the  fact  that  genetic  recombination  among  heterologous  IBVs 
could lead to the emergence of new variants, and result in genetic diversity 
(Kottier et al., 1995; Lee & Jackwood, 2000; Lim et al., 2011). Recombination 
is believed to decrease the mutation rate and associated constraints which are 
responsible  for  the genetic diversification  that  results  in  emergence  of new 
variants of coronaviruses (Worobey & Holmes, 1999). 
Taken together, point mutations, strong selective pressure and to some 
extent recombination events in the spike gene are contributing factors to the 
generation  of  new  emerging  variants  and  genetic  diversity  that  leads  to 
constant evolution of the virus.  
Phylogenetic  analysis  based  on  partial  S1  and  complete  S  gene 
sequences revealed four distinct clusters: Massachusetts, QX-like, Italy-02 and 
4/91 genotypes. Swedish isolates from 1995 to 1999 clustered together with 
strains from China, Korea, Spain and Thailand, represented as Massachusetts-
type. The Swedish isolates from 2009-2010 formed a group with sequences 
from France, Italy, the Netherlands, Spain and UK, which belonged to the QX-
like genotype (Paper I). The analysis revealed new branches within the QX-
like genotype, indicative of the emergence of new strains. Furthermore, this 
signifies a shift from predominantly classical Massachusetts viruses in 1990s to 
emerging QX-like viruses dominating in Sweden. QX-like emerging viruses 
showed close relatedness to QX-like types present in other European countries. 
Hence, the emergence of these QX-like viruses could be attributed to trade and 
to importation of chickens and poultry products from other European countries. 
Alternatively, indirect routes may have contributed to the introduction of the 
QX-like  strains  in  Sweden.  As  has  been  reported,  QX-like  viruses  were 
detected in France in 2004 close to the border regions of Belgium and in The 
Netherlands where these viruses were already prevalent (Worthington et al., 
2008). The introduction of viruses by wild or migratory birds as further hosts 
and  carriers  of  IBV  still  remains  to  be  investigated,  although  it  has  been 
reported  that  migratory  birds  play  an  important  role  as  reservoirs,  in 
transmission and in long-distance carriage of coronaviruses (Chen et al., 2009; 
Hughes et al., 2009; Muradrasoli et al., 2010). 
As reported in Paper III, phylogenetic analysis of the complete S gene 
revealed variable relationships among the investigated avian and mammalian 
coronaviruses.  The  high  genetic  divergence  observed  in  the  coronaviral 
genomes is likely due to host specificity and continuous mutations in this gene. 29 
Furthermore, this genetic diversity in the spike gene may affect the biology of 
viruses, as changes favour  interspecies transmission and tissue tropism that 
leads to adaptation to new host species.  Previously, a shift of tissue tropism in 
IBV  has  been  described  (Zhou  et  al.,  2004;  Liu  et  al.,  2006),  resulting  in 
infection of a wide range of avian host species (Cavanagh, 2005).    
As  described  in  Paper  III,  with  the  help  of  an  in  silico  approach, 
comparative differences were observed between QX-like and Massachusetts 
strains,  notably,  in  N-glycosylation  sites,  palmitoylation  domains, 
phosphorylation  peptides,  cleavage  sites,  LRR  motifs  and  primary  and 
secondary structures of the spike glycoprotein. The changes in these molecular 
and structural characteristics may influence the infection biology of the virus. 
However,  the  predicted  characteristics  need  to  be  further  investigated  in 
biological assays to determine if they relate to differences in the behavior of 
these viruses in vivo.  
4.2  Analysis of full-length genome sequence of an emerging 
QX-like isolate of IBV (Paper II) 
Recently, QX-like viruses are taking relevance in infections in chicken flocks 
in most countries of Europe, posing problems for control of avian infectious 
bronchitis. Thus, Paper II provides novel information about the genome of an 
European  QX-like  virus  responsible  for  one  such  outbreaks.  The  complete 
genome of isolate CK/SWE/0658946/10 consists of six genes (27,664 nt) with 
ten open reading frames (ORFs) flanked by 5  and 3  UTRs. In the comparison 
of full-length genomes, the isolate was closely related to the sequence of the 
strain ITA/90254/2005, with lower sequence similarity shown to the classical 
Massachusetts strain. The sequences of the individual ORF1a, ORF1b, S and 
M  genes  shared  lower  similarities  to  the  corresponding  sequences  of  the 
classical Massachusetts strain. The lower similarities in the two viral genomes 
may be the result of high nucleotide substitution rates or to strong selective 
constraints. The evolutionary pressure analysis of the genome showed strong 
selective constraints especially in the replicase and spike genes, with a high 
substitutions rate across the genes. Also, recombination events were observed 
in  the  N  gene  of  the  isolate.  A  high  rate  of  mutation  and  strong  selective 
constraints  across  the  genome  contribute  to  high  genetic  divergence  of  the 
virus. 
In  addition  to  the  clinical  features  in  flocks  infected  with  QX-like 
viruses,  high  sequence  similarities  and  close  phylogenetic  relatedness  was 
found to the viruses isolated from other European countries. Taken together, 
these characteristics explain the high genetic relatedness of QX-like viruses 30 
circulating in Europe. Currently,  the wide spread of the QX-like viruses in 
Europe may be associated with intensified poultry husbandry and less-strict 
border controls on the continent.  
The generated sequence data and information will be useful for potential 
application of generation of an infectious clone, determination of pathogenic 
nature of the virus, and has relevance for diagnostics and vaccines. 
4.3  Development of VOCMA for broad detection and typing of 
IBV (Paper IV) 
The  studies  described  in  Papers  I,  II  and  III  have  demonstrated  that  high 
sequence  variability,  strong  selective  pressure,  recombinant  events,  and 
variation in molecular motifs, especially in the spike gene are responsible for 
genetic divergence within IBV. This high genetic diversity poses a problem for 
diagnostics and especially for the accurate typing of strains involved in new 
outbreaks. The majority of the currently used diagnostic methods are not able 
to  differentiate  and  type  the  different  variants  of  IBV.  This  may  lead  to 
diagnostic problems, especially when multiple genotypes are co-circulating in 
a region, such as with the co-existence of Mass 41, Italy-02, 4/91, QX-like and 
D274 recently in Europe.  
Considering  these  problems,  there  is  a  need  for  an  assay  that  could 
simultaneously detect and type different IBV variants.  For this reason, we 
have designed and developed an assay for specific and simultaneous detection 
of IBV QX-like, Italy-02, M41, 4/91 and D274 using a new technique, termed 
VOCMA (Öhrmalm et al., 2012).  
In order to provide broad-range detection, the assay targets the capsid 
and  hypervariable  sequence  region  of  the  S  gene  that  facilitates  the 
simultaneous typing of the various viral variants.  Being based on the variation 
tolerance  and  multiple  detection  principle,  the  assay  has  great  potential  to 
target divergent sequences in the genomes of the different variants of IBV. 
Two sets of genotype specific detection probes (long and short probes) were 
designed to facilitate the detection of the specific genotype: long probes to 
create a broader variation tolerance (48-62 nucleotides) and short probes to 
gain  higher  specificity  (33-36  nucleotides).  Both  probe-sets  revealed  high 
specificity that could distinguish the targeted IBV genotypes from each other. 
The analytical specificity of the assay was evaluated with the selected set of 
different genotypic variants. The strong signals detected were specific to their 
respective  targets.  The  possible  cross-reactions  in  the  IBV  assay  were 
evaluated and no cross-reactivity or non-specific signals were detected when 
tested  on  heterologous  avian  and  bovine  coronaviruses.  So  far,  the  results 31 
demonstrated a low possibility of false positive reactions that could result from 
the presence of other coronaviruses in the field samples.  
The performance of the assay was evaluated by testing 46 samples for 
the five targeted IBV genotypes. The detected signals were specific to their 
respective  targets.  The  positive  samples  were  amplified  and  sequenced  by 
targeting in the spike gene, and the sequence analysis confirmed detection of 
the correct genotype by the assay. 
The strength of this assay is that it is able to detect and simultaneously 
genotype  a  wide  range  of  virus  variants  of  IBV.  A  weakness  is  that,  the 
sensitivity of VOCMA is lower, compared to the real-time RT-PCR. Therefore, 
a considerable amount of virus in the sample is needed for the detection by 
VOCMA. Further work is required to increase the sensitivity of the assay. 
In summary, the developed VOCMA method was found to be useful for 
the  simultaneous  detection  and  typing  of  IBV  strains  representing  different 
genotypes. The assay is relatively fast and specific, and it provides a new tool 
for  surveillance  and  monitoring  of  IBV  infections  and  for  large-scale 
epidemiological studies.   
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5  Conclusions 
  The Massachusetts-type strains, which were predominant in Sweden in 
the 1990s, have been replaced by QX-like variants. The emergence of 
these QX-like viruses is likely the consequence of their introduction 
from other European countries.  
  The  complete  genome  sequence  data  and  the  phylogenetic  analysis 
have revealed that the genome of IBV is under a continuous process of 
evolution,  due  to  mutations,  strong  selective  pressure  and 
recombination events. The data will be useful in further evolutionary 
studies and for a better understanding of the infection biology of the 
virus.  Furthermore,  the  information  will  be  helpful  for  the 
development of novel diagnostic assays and vaccine candidates.   
  This  study  provided  insights  showing  that  functional  and  structural 
motifs  in  the  spike  glycoprotein  are  different  between  the  classical 
Massachusetts  and  emerging  QX-like  genotypes.  The  predicted 
characteristics have to be further investigated in biological assays, in 
order to determine if they relate to differences in the behaviour of the 
viruses under in vivo conditions.  
  The multiplex VOCMA assay provides a method for the molecular 
detection  and  typing  of  the  diverse  IBV  genotypes  circulating  in 
Europe. Furthermore, this assay is considered to be a practical new 
tool  for  the  monitoring  of  IBV  infections  and  for  large-scale 
epidemiological studies.  
  The  observations  concerning  the  genome  construction  and 
evolutionary aspects of IBV variants, as well as the development of a 
new  detection  and  typing  assay,  provide  information  and  new 
possibilities to combat infectious bronchitis, a viral disease of global 
importance.     
 34 
   35 
6  Future prospects 
This thesis has dealt with the characterization and detection of IBV variants 
currently  circulating  in  Sweden  and  other  European  countries.  The 
characterization  was  intended  to  provide  a  better  understanding  of  the 
molecular  biology  of  the  virus  and  to  investigate  the  factors  behind  the 
continuous emergence of new genetic variants of this virus. The possibility 
detect  the  various  genotypes  present  in  Europe  was  improved  by  the 
development of a new genotyping assay. While the present research will be 
helpful  for  diagnosis,  epidemiology,  disease  monitoring  and  adoption  of 
effective  control  measures,  further  research questions have  arisen  that  need 
follow-up studies:   
  The  continuous  variation  of  IBV  makes  it  very  difficult  to  control 
infectious  bronchitis  by  using  live  attenuated  vaccines  for 
immunization  (Cavanagh,  2003).  The  knowledge  gained  from  this 
thesis can be useful for the development new vaccine candidates that 
would  provide  adequate  immunity,  and  protect  poultry  against 
multiple IBV variants. 
  The biological characteristics of different strains of IBV, particularly 
with regard to virulence, need to be further investigated. In addition, 
the  pathogenesis  of  IB  induced  by  the  currently  circulating  viral 
variants needs to be further studied.  
  As the egg inoculation studies are time consuming and cumbersome it 
would be of great value to establish susceptible cell lines and powerful 
systems of virus production, in order to facilitate studies on the virus 
and on the infection it causes.  
  Further investigations are needed to study tissue tropism, particularly 
of the new virus variants, in order to better understand the changes in 
virus behavior and the development of various disease manifestations, 36 
ranging from classical respiratory disease to symptoms associated with 
the new and emerging strains.   
  Continued  research  is  needed  on  reverse  genetics  for  better 
understanding of the molecular interactions and for the development 
of novel IBV vaccines.   
  The  role  of  various  animal  species  for  transmission  of  IB  or  IBV-
related coronaviruses, such as wild birds, bats etc., requires further 
study.  
This  research  would  be  helpful  for  improved  prevention  and  for  more 
effective control of this disease.   
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7  Populärvetenskaplig sammanfattning 
Infektiöst  bronkitvirus  (IBV)  drabbar  höns  men  även  andra  fågelarter  som 
lever i nära anslutning till tamhöns. Det har påvisats hos fasaner, pärlhöns, 
kricka och påfågel. Sjukdomen infektiös bronkit (IB) är en för slaktkyckling- 
och äggproduktion ekonomiskt över hela världen viktig sjukdom förutom att 
den negativt påverkar fåglarnas välbefinnande.  
Virushöljets glykoprotein (spike, S) binder viruspartikeln till värdcellen, 
är målstruktur vid neutralisation av virus och har betydelse för induktion av 
skyddande immunsvar. Ett antal studier har fokuserat på att karaktärisera en 
del av gensekvensen för spikegenen, S1. Vilka andra regioner i genomet som 
har  betydelse  för  den  genetiska  diversiteten  och  variationen  är  relativt 
outforskade, inte identifierade eller differentierade. Av virusets egenskap att 
förändras och utvecklas för att undgå värdcellens försvar följer att det ständigt 
uppstår  nya  IBV-stammar  genom  mutationer  i  och  rekombination  av 
arvsmassan. I synnerhet rekombinationer kan inte påvisas om endast en kort 
sekvens  av  S1  analyseras.  Den  genetiska  variationen  hos  IBV  innebär 
utmaningar  för  molekylär  epidemiologi,  diagnostik  och  sjukdomskontroll 
genom  vaccination.  Därför  behövs  lämpliga  verktyg  för  att  ställa  en  snabb 
diagnos och samtidigt typa det påvisade viruset för epidemiologiska studier. 
Avhandlingens syfte är att förstå den funktionella genetiska variationen 
hos IBV och att hitta de specifika sekvenserna (sekvensmotiven) bakom denna 
variation. Dessutom har en metod för molekylär detektion och typning av IBV-
varianter  som  nu  cirkulerar  i  Europa  utvecklats.  De  inledande  studierna 
påvisade förekomst av sekvensmotiv i spike-genen såväl som andra faktorer 
bakom bildandet av nya IBV-stammar (Arbete I). För att ytterligare utforska de 
molekylära särdragen hos de nya virus som nu förekommer i många europeiska 
länder  helgenomsekvenserades  ett  svenskt  isolat  av  typen  QX-liknande. 
Studien  visar  att  detta  genom  har  uppstått  genom  mutationer  och 
selektionstryck som även omfattar N-genen, som antagits vara konserverad. 38 
Det  är  det  första  IBV  QX-liknande  virus  från  Europa  som 
helgenomsekvenserats, och är nära besläktat med de virus som har orsakat IB i 
flera europeiska länder (Arbete II). IBV har inte tidigare karaktäriserats med 
avseende på förändringar i funktionella sekvensmotiv som kan relateras till 
virusets  biologiska  funktioner  såsom  positioner  för  N-glykosylering, 
palmitoylering,  fosforylering  av  peptider,  klyvningsställen,  primär-  och 
sekundärstruktur.  Avhandlingen  jämför  dessa  sekvensmotiv  i  spike-genen 
mellan  Massachusettsstammen  och  QX-liknande  stammar  och  visar  att 
avgörande  sekvensmotiv  skiljer  sig  mellan  stammarna  Skillnaderna  i 
sekvensmotiv mellan olika stammar behöver undersökas också med biologiska 
metoder för att avgöra om de är förknippade med biologiska skillnader in vivo. 
Den genetiska diversiteten hos stammar av coronavirus som infekterar fåglar, 
människor,  fladdermöss  och  andra  djurarter  kan  vara  associerad  med 
specificitet för värddjuret (Arbete III). För att förbättra en molekylär detektion 
av de olika IBV-stammar som cirkulerar i Västeuropa utvecklades en multiplex 
PCR-baserad  analys.  Analysen  har  optimerats  för  simultan  detektion  och 
typning av IBV baserad på amplifiering av kapsid- respektive S-genen. Den 
har  genom  att  vara  både  multipel  och  tolerant  mot  genetisk  variabilitet 
möjlighet att påvisa olika varierande sekvenser och är ett värdefullt verktyg för 
både  övervakning  av  IBV-infektioner  och  för  storskaliga  epidemiologiska 
studier (Arbete IV), och är ett värdefullt verktyg för både övervakning av IBV-
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